Etazolate (hydrochloride), CAS [[35838-58-5]]

Produktübersicht

• Artikelname: Etazolate (hydrochloride), CAS [[35838-58-5]]
• Artikelnummer: MCE-HY-100936
• Hersteller Artikelnummer: HY-100936
• Alternativnummer: MCE-HY-100936-10MG,MCE-HY-100936-10MMX1ML,MCE-HY-100936-5MG,MCE-HY-100936-25MG,MCE-HY-100936-100MG,MCE-HY-100936-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: SQ 20009, EHT 0202 (hydrochloride)

Produktbeschreibung

Etazolate hydrochloride (SQ 20009) is an orally active, selective inhibitor of type 4 phosphodiesterase (PDE4) with an IC50 of 2 µM. Etazolate hydrochloride is a gamma-aminobutyric acid A (GABAA) receptor regulator. Etazolate hydrochloride is an alpha-secretase activator and induced the production of soluble amyloid precursor protein (sAPPalpha). Etazolate hydrochloride, a pyrazolopyridine class derivative, increases cAMP levels. Etazolate hydrochloride has anxiolyticlike, antidepressant-like and anti-inflammatory effects[1][2][3][4][5].

Produkteigenschaften

• Molekulargewicht: 325.79
• Reinheit: 98.00
• CAS Nummer: [35838-58-5]
• Formel: C14H20ClN5O2
• Target-Kategorie: GABA Receptor,Phosphodiesterase (PDE)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound